NCT03111849
- Conditions
- Atrophy, COPD, Chronic Disease, +17 more
- Locations
-
- CHU Clermont-Ferrand Clermont-Ferrand, France
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
4,016 public trials
394 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01942499
- Conditions
- Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease, +8 more
- Locations
-
- Trillium Health Partners- Credit Valley Hospital Mississauga, Ontario, Canada
- St. Joseph's Care Group Thunder Bay, Ontario, Canada
- West Park Healthcare Centre Toronto, Ontario, Canada
- Lakeridge Health Whitby, Ontario, Canada
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT03496376
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Dokuz Eylül Üniversitesi School of Physical Therapy and Rehabilitation Izmir, Turkey (Türkiye)
NCT02347085
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
Not specified
NCT02859194
- Conditions
- ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, Bronchial Diseases, +27 more
- Locations
-
- Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine Seoul, South Korea
NCT00914264
- Conditions
- Apnea, COPD & OSA, Chronic Disease, +14 more
- Locations
-
- Division of Thoracic Medicine, Chang Gung Memorial Hospital Taipei, Taiwan
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Dimitrovgrad, Bulgaria
- GSK Investigational Site Lovech, Bulgaria
- GSK Investigational Site Pleven, Bulgaria
- GSK Investigational Site Plovdiv, Bulgaria
NCT01053988
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Montgomery, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Scottsdale, Arizona, United States
Completed
CODP Imaging From a Dose Perspective
NCT03581110
- Conditions
- Chronic Disease, Death, Disease Attributes, +7 more
- Locations
-
Not specified